drugset / Trial / NCT00322621

Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

NCT00322621

Phase 4 Completed 216 enrolled Eli Lilly and Company Boehringer Ingelheim · collab
NaSingle-groupOpen-labelTreatment

Summary

To determine if duloxetine 60 mg once daily can work up to 6 months in treating pain from Diabetic Neuropathy.

Timeline

Start
2006-04
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral
Subject Duloxetine Small molecule 120 mg Oral

Indications